Hibrigen Biotechnology

is a Turkey-based startup founded in 2010, specializing in the production of molecular biology products and medical devices. The company's slogan "Molecular Biology Products. Research is in our genes," highlights its commitment to providing reliable and high-quality products for scientific research. Hibrigen's focus on local production aligns with the growing emphasis on domestic manufacturing in the healthcare industry. One notable aspect of Hibrigen is its self-sufficiency in product development, with the design, production, and validation of its offerings all taking place within its own laboratory. This approach allows the company to maintain control over the quality of its products and stay abreast of the latest innovations, offering a competitive advantage in the market. In terms of investment, Hibrigen secured a $100.00K seed round investment from Sirket Ortağım Angel Investors Network in January 31, 2019. This investment reflects external confidence in the company's potential and may facilitate its expansion and R&D efforts. With its focus on providing essential tools for scientific research, adherence to quality management system certificates ISO 9001:2015 and EN ISO:13485:2016 for its medical devices, and strong support from investors, Hibrigen Biotechnology shows promise in contributing to advancements in the health care and manufacturing industries.